Literature DB >> 10585395

Cullin 4A associates with the UV-damaged DNA-binding protein DDB.

P Shiyanov1, A Nag, P Raychaudhuri.   

Abstract

The damaged DNA-binding protein (DDB) is believed to be involved in DNA repair, and it has been linked to the repair deficiency disease xeroderma pigmentosum. DDB also exhibits transcriptional activities. DDB binds to the activation domain of E2F1 and stimulates E2F1-activated transcription. Here we provide evidence that DDB or DDB-associated proteins are targets of cullin 4A (CUL-4A). CUL-4A is a member of the cullin family of proteins, which are believed to be ubiquitin-protein isopeptide ligases (type E3). The CUL-4A gene has been shown to be amplified and up-regulated in breast carcinomas. In this study, we identify CUL-4A as one of the DDB-associated proteins. CUL-4A co-immunoprecipitates with DDB, but not with a naturally occurring mutant of DDB. Moreover, CUL-4A in HeLa nuclear extracts co-purifies with DDB, suggesting they are parts of the same complex. The observation provides insights how CUL-4A, through an interaction with DDB, might be playing a role in the development of breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585395     DOI: 10.1074/jbc.274.50.35309

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  89 in total

Review 1.  Navigating the nucleotide excision repair threshold.

Authors:  Liren Liu; Jennifer Lee; Pengbo Zhou
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

2.  Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements.

Authors:  Anne F Nichols; Toshiki Itoh; Francesca Zolezzi; Stephanie Hutsell; Stuart Linn
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

3.  Cop9/signalosome subunits and Pcu4 regulate ribonucleotide reductase by both checkpoint-dependent and -independent mechanisms.

Authors:  Cong Liu; Kelly A Powell; Kirsten Mundt; LeJung Wu; Antony M Carr; Thomas Caspari
Journal:  Genes Dev       Date:  2003-04-14       Impact factor: 11.361

4.  The Clr7 and Clr8 directionality factors and the Pcu4 cullin mediate heterochromatin formation in the fission yeast Schizosaccharomyces pombe.

Authors:  Geneviève Thon; Klavs R Hansen; Susagna Padrissa Altes; Deepak Sidhu; Gurjeet Singh; Janne Verhein-Hansen; Michael J Bonaduce; Amar J S Klar
Journal:  Genetics       Date:  2005-09-12       Impact factor: 4.562

5.  DDB1 maintains genome integrity through regulation of Cdt1.

Authors:  Courtney A Lovejoy; Kimberli Lock; Ashwini Yenamandra; David Cortez
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

6.  Dimerization of CUL7 and PARC is not required for all CUL7 functions and mouse development.

Authors:  Jeffrey R Skaar; Takehiro Arai; James A DeCaprio
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

7.  DDB2, an essential mediator of premature senescence.

Authors:  Nilotpal Roy; Tanya Stoyanova; Carmen Dominguez-Brauer; Hyun Jung Park; Srilata Bagchi; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

Review 8.  Regulation of DNA damage response pathways by the cullin-RING ubiquitin ligases.

Authors:  Jeffrey Hannah; Pengbo Zhou
Journal:  DNA Repair (Amst)       Date:  2009-02-23

9.  DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.

Authors:  Nilotpal Roy; Prashant V Bommi; Uppoor G Bhat; Shaumick Bhattacharjee; Indira Elangovan; Jing Li; Krushna C Patra; Dragana Kopanja; Adam Blunier; Richard Benya; Srilata Bagchi; Pradip Raychaudhuri
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

10.  Cul4A and DDB1 associate with Skp2 to target p27Kip1 for proteolysis involving the COP9 signalosome.

Authors:  Tanya Bondar; Anna Kalinina; Lyne Khair; Dragana Kopanja; Alo Nag; Srilata Bagchi; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.